Literature DB >> 20188458

Predictive factors for ipsilateral recurrence after nephron-sparing surgery in renal cell carcinoma.

Jean-Christophe Bernhard1, Allan J Pantuck, Hervé Wallerand, Maxime Crepel, Jean-Marie Ferrière, Laurent Bellec, Sylvie Maurice-Tison, Grégoire Robert, Baptiste Albouy, Gilles Pasticier, Michel Soulie, David Lopes, Bertrand Lacroix, Karim Bensalah, Christian Pfister, Rodolphe Thuret, Jacques Tostain, Alexandre De La Taille, Laurent Salomon, Clément Abbou, Marc Colombel, Arie S Belldegrun, Jean-Jacques Patard.   

Abstract

BACKGROUND: Ipsilateral recurrence after nephron-sparing surgery (NSS) is rare, and little is known about its specific determinants.
OBJECTIVE: To determine clinical or pathologic features associated with ipsilateral recurrence after NSS performed for renal cell carcinoma (RCC). DESIGN, SETTING, AND PARTICIPANTS: We analysed 809 NSS procedures performed at eight academic institutions for sporadic RCCs retrospectively. MEASUREMENTS: Age, gender, indication, tumour bilaterality, tumour size, tumour location, TNM stage, Fuhrman grade, histologic subtype, and presence of positive surgical margins (PSMs) were assessed as predictors for recurrence in univariate and multivariate analysis by using a Cox proportional hazards regression model. RESULTS AND LIMITATIONS: Among 809 NSS procedures with a median follow-up of 27 (1-252) mo, 26 ipsilateral recurrences (3.2%) occurred at a median time of 27 (14.5-38.2) mo. In univariate analysis, the following variables were significantly associated with recurrence: pT3a stage (p=0.0489), imperative indication (p<0.01), tumour bilaterality (p<0.01), tumour size >4cm (p<0.01), Fuhrman grade III or IV (p=0.0185), and PSM (p<0.01). In multivariate analysis, tumour bilaterality, tumour size >4cm, and presence of PSM remained independent predictive factors for RCC ipsilateral recurrence. Hazard ratios (HR) were 6.31, 4.57, and 11.5 for tumour bilaterality, tumour size >4cm, and PSM status, respectively. The main limitations of this study included its retrospective nature and a short follow-up.
CONCLUSIONS: RCC ipsilateral recurrence risk after NSS is significantly associated with tumour size >4cm, tumour bilaterality (synchronous or asynchronous), and PSM. Careful follow-up should be advised in patients presenting with such characteristics.
Copyright © 2010 European Association of Urology. All rights reserved.

Entities:  

Mesh:

Year:  2010        PMID: 20188458     DOI: 10.1016/j.eururo.2010.02.019

Source DB:  PubMed          Journal:  Eur Urol        ISSN: 0302-2838            Impact factor:   20.096


  17 in total

Review 1.  Surgical Margins in Nephron-Sparing Surgery for Renal Cell Carcinoma.

Authors:  Dean D Laganosky; Christopher P Filson; Viraj A Master
Journal:  Curr Urol Rep       Date:  2017-01       Impact factor: 3.092

2.  Long-term oncological outcomes after robotic partial nephrectomy for renal cell carcinoma: a prospective multicentre study.

Authors:  Jean-Baptiste Beauval; Benoit Peyronnet; Thibaut Benoit; Bastien Cabarrou; Thomas Seisen; Mathieu Roumiguié; Benjamin Pradere; Zine-Eddine Khene; Quentin Manach; Gregory Verhoest; Mathieu Thoulouzan; Jerome Parra; Nicolas Doumerc; Romain Mathieu; Christophe Vaessen; Michel Soulié; Morgan Roupret; Karim Bensalah
Journal:  World J Urol       Date:  2018-02-09       Impact factor: 4.226

3.  Local Recurrence Following Resection of Intermediate-High Risk Nonmetastatic Renal Cell Carcinoma: An Anatomical Classification and Analysis of the ASSURE (ECOG-ACRIN E2805) Adjuvant Trial.

Authors:  Ziho Lee; Opeyemi A Jegede; Naomi B Haas; Michael R Pins; Edward M Messing; Judith Manola; Christopher G Wood; Christopher J Kane; Michael A S Jewett; Keith T Flaherty; Janice P Dutcher; Robert S DiPaola; Robert G Uzzo
Journal:  J Urol       Date:  2019-10-09       Impact factor: 7.450

Review 4.  Repeat partial nephrectomy: surgical, functional and oncological outcomes.

Authors:  Brian Shuch; W Marston Linehan; Gennady Bratslavsky
Journal:  Curr Opin Urol       Date:  2011-09       Impact factor: 2.309

Review 5.  The Diagnosis, Treatment, and Follow-up of Renal Cell Carcinoma.

Authors:  Christian Doehn; Viktor Grünwald; Thomas Steiner; Markus Follmann; Heidrun Rexer; Susanne Krege
Journal:  Dtsch Arztebl Int       Date:  2016-09-05       Impact factor: 5.594

Review 6.  Positive surgical margins in nephron-sparing surgery: risk factors and therapeutic consequences.

Authors:  Julie Steinestel; Sandra Steffens; Konrad Steinestel; Andres Jan Schrader
Journal:  World J Surg Oncol       Date:  2014-08-08       Impact factor: 2.754

7.  Self-assessment of surgical technique leads to reduction of positive surgical margins in partial nephrectomy.

Authors:  Igor Sorokin; Michael A Feuerstein; Paul Feustel; Ronald P Kaufman
Journal:  J Robot Surg       Date:  2014-08-20

8.  Predictors of positive surgical margins in patients undergoing partial nephrectomy: A large single-center experience.

Authors:  Ercan Malkoç; Matthew J Maurice; Önder Kara; Daniel Ramirez; Ryan J Nelson; Julien Dagenais; Khaled Fareed; Amr Fergany; Robert J Stein; Pascal Mouracade; Jihad H Kaouk
Journal:  Turk J Urol       Date:  2019-01-01

9.  The subclassification of papillary renal cell carcinoma does not affect oncological outcomes after nephron sparing surgery.

Authors:  Pierre Bigot; Jean-Christophe Bernhard; Inderbir S Gill; Nam Son Vuong; Grégory Verhoest; Vincent Flamand; Boris Reix; Evren Suer; Ilker Gökce; Jean Baptiste Beauval; François Xavier Nouhaud; Masatoshi Eto; Eduard Baco; Toru Matsugasumi; Yvonne Chowaniec; Jérôme Rigaud; Claire Lenormand; Christian Pfister; Jean François Hetet; Guillaume Ploussard; Morgan Roupret; Priscilla Léon; Adnan El Bakri; Stéphane Larré; Xavier Tillou; Arnaud Doerfler; Aurélien Descazeaud; Nicolas Koutlidis; Alexandre Schneider; Philippe Sebe; Alexandre Ingels; Abdel Rahmène Azzouzi; Michel Soulié; Arnaud Méjean; Karim Bensalah; Jean-Jacques Patard
Journal:  World J Urol       Date:  2015-07-07       Impact factor: 4.226

10.  Advancements in laparoscopic partial nephrectomy: expanding the feasibility of nephron-sparing.

Authors:  Eugene J Pietzak; Thomas J Guzzo
Journal:  Adv Urol       Date:  2012-05-09
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.